LD-2 disclosure · 2nd Quarter - Report
COSMOSID, INC.
Coverage · No income or expenses were reported on this filing.
Client
- Name
- COSMOSID, INC.
- Description
- Pharmaceutical Preparation Manufacturing
- Location
- Maryland · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesDefense
Bio/Pathogen detection issues.
LobbyistsKEVIN F KELLY · EZANA EMMANUEL · LAUREN LIPIN
Science/Technology
No lobbying activity.
LobbyistsKEVIN F KELLY
Homeland Security
Bio/Pathogen detection issues; and Funding under Broad Agency Announcements Reauthorization of the Pandemic and All-Hazards Preparedness Act, BARDA issues.
LobbyistsKEVIN F KELLY
Budget/Appropriations
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2013, Bio/Pathogen detection issues. Public Law 113-6, Consolidated and Further Continuing Appropriations Act, FY2013, Bio/Pathogen detection issues. H.J.Res.117, Continuing Appropriations Resolution, FY2013, Sequestration issues. H.R.8, American Taxpayer Relief Act of 2012, Sequestration issues generally.
LobbyistsKEVIN F KELLY · EDWARD LONG